2015 ICD-9-CM Diagnosis Code 282.2
Anemias due to disorders of glutathione metabolism
- 2015
- Billable Thru Sept 30/2015
- Non-Billable On/After Oct 1/2015
- ICD-9-CM 282.2 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 282.2 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
Convert to ICD-10-CM:
282.2 converts approximately to:
- 2015/16 ICD-10-CM D55.0 Anemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency
Or:
- 2015/16 ICD-10-CM D55.1 Anemia due to other disorders of glutathione metabolism
Approximate Synonyms
- Anemia due to G6PD deficiency
- Anemia due to glutathione reductase deficiency
- Anemia due to pentose phosphate pathway defect
- Anemia, G6PD deficiency
- Anemia, glutathione reductase deficiency
- Drug-induced enzyme deficiency anemia
- Erythrocyte enzyme deficiency
- Erythrocyte uridine diphosphate galactose-4-epimerase deficiency
- Favism
- G-6-PD class I variant anemia
- G-6-PD class II variant anemia
- G-6-PD class III variant anemia
- G-6-PD class IV variant anemia
- G-6-PD class V variant anemia
- G-6-PD variant enzyme deficiency anemia
- Glucose phosphate isomerase deficiency
- Glucose-6-phosphate dehydrogenase deficiency anemia
- Glutathione synthase deficiency without 5-oxoprolinuria
- Gluthathione peroxidase deficiency
- Gluthathione synthetase deficiency
- Hemolytic anemia due to glutathione metabolism disorder
- Hereditary nonspherocytic hemolytic anemia (HNSHA) due to glutathione reductase deficiency (disorder)
- Hereditary nonspherocytic hemolytic anemia due to glutathione reductase deficiency
- Hereditary nonspherocytic hemolytic anemia due to glutathione synthetase deficiency
- HNSHA due to glutathione reductase deficiency
- Leukocyte glucose-6-phosphate dehydrogenase deficiency
- Muscle phosphofructokinase deficiency
- Neonatal jaundice with glucose-6-phosphate dehydrogenase deficiency
- Neutrophil lactoferrin deficiency
- Pentose disorder
Applies To
- Anemia:
- 6-phosphogluconic dehydrogenase deficiency
- enzyme deficiency, drug-induced
- erythrocytic glutathione deficiency
- glucose-6-phosphate dehydrogenase [G-6-PD] deficiency
- glutathione-reductase deficiency
- hemolytic nonspherocytic (hereditary), type I
- Disorder of pentose phosphate pathway
- Favism
ICD-9-CM Volume 2 Index entries containing back-references to
282.2:
- Anemia 285.9
- with
- disorder of
- anaerobic glycolysis 282.3
- pentose phosphate pathway 282.2
- koilonychia 280.9
- 6-phosphogluconic dehydrogenase deficiency 282.2
- autohemolysis of Selwyn and Dacie (type I) 282.2
- Baghdad Spring 282.2
- congenital (following fetal blood loss) 776.5
- aplastic 284.01
- due to isoimmunization NEC 773.2
- Heinz-body 282.7
- hereditary hemolytic NEC 282.9
- nonspherocytic
- type I 282.2
- type II 282.3
- pernicious 281.0
- spherocytic (see also Spherocytosis) 282.0
- Dacie's (nonspherocytic)
- type I 282.2
- type II 282.3
- deficiency 281.9
- 2, 3 diphosphoglycurate mutase 282.3
- 2, 3 PG 282.3
- 6-PGD 282.2
- 6-phosphogluronic dehydrogenase 282.2
- amino acid 281.4
- combined B12 and folate 281.3
- enzyme, drug-induced (hemolytic) 282.2
- erythrocytic glutathione 282.2
- folate 281.2
- folic acid 281.2
- G-6-PD 282.2
- GGS-R 282.2
- glucose-6-phosphate dehydrogenase (G-6-PD) 282.2
- glucose-phosphate isomerase 282.3
- glutathione peroxidase 282.2
- glutathione reductase 282.2
- glyceraldehyde phosphate dehydrogenase 282.3
- GPI 282.3
- G SH 282.2
- hexokinase 282.3
- iron (Fe) 280.9
- nutritional 281.9
- with
- poor iron absorption 280.9
- specified deficiency NEC 281.8
- due to inadequate dietary iron intake 280.1
- specified type NEC 281.8
- of or complicating pregnancy 648.2
- pentose phosphate pathway 282.2
- PFK 282.3
- phosphofructo-aldolase 282.3
- phosphofructokinase 282.3
- phosphoglycerate kinase 282.3
- PK 282.3
- protein 281.4
- pyruvate kinase (PK) 282.3
- TPI 282.3
- triosephosphate isomerase 282.3
- vitamin B12 NEC 281.1
- due to
- antineoplastic chemotherapy 285.3
- blood loss (chronic) 280.0
- chemotherapy, antineoplastic 285.3
- defect of Embden-Meyerhof pathway glycolysis 282.3
- disorder of glutathione metabolism 282.2
- drug - see Anemia, by type (see also Table of Drugs and Chemicals)
- chemotherapy, antineoplastic 285.3
- fetal blood loss 776.5
- fish tapeworm (D. latum) infestation 123.4
- glutathione metabolism disorder 282.2
- hemorrhage (chronic) 280.0
- hexose monophosphate (HMP) shunt deficiency 282.2
- impaired absorption 280.9
- loss of blood (chronic) 280.0
- myxedema 244.9
- Necator americanus 126.1
- prematurity 776.6
- selective vitamin B12 malabsorption with proteinuria 281.1
- enzyme deficiency, drug-induced 282.2
- erythrocytic glutathione deficiency 282.2
- favism 282.2
- G-6-PD 282.2
- glucose-6-phosphate dehydrogenase deficiency 282.2
- glutathione-reductase deficiency 282.2
- hemolytic 283.9
- acquired 283.9
- with hemoglobinuria NEC 283.2
- autoimmune (cold type) (idiopathic) (primary) (secondary) (symptomatic) (warm type) 283.0
- due to
- cold reactive antibodies 283.0
- drug exposure 283.0
- warm reactive antibodies 283.0
- fragmentation 283.19
- idiopathic (chronic) 283.9
- infectious 283.19
- non-autoimmune 283.10
- toxic 283.19
- traumatic cardiac 283.19
- acute 283.9
- due to enzyme deficiency NEC 282.3
- fetus or newborn (see also Disease, hemolytic) 773.2
- Lederer's (acquired infectious hemolytic anemia) 283.19
- autoimmune (acquired) 283.0
- chronic 282.9
- cold type (secondary) (symptomatic) 283.0
- congenital (spherocytic) (see also Spherocytosis) 282.0
- nonspherocytic - see Anemia, hemolytic, nonspherocytic, congenital
- drug-induced 283.0
- due to
- cardiac conditions 283.19
- drugs 283.0
- enzyme deficiency NEC 282.3
- presence of shunt or other internal prosthetic device 283.19
- thrombotic thrombocytopenic purpura 446.6
- elliptocytotic (see also Elliptocytosis) 282.1
- familial 282.9
- hereditary 282.9
- due to enzyme deficiency NEC 282.3
- specified NEC 282.8
- idiopathic (chronic) 283.9
- infectious (acquired) 283.19
- mechanical 283.19
- microangiopathic 283.19
- nonautoimmune 283.10
- nonspherocytic
- congenital or hereditary NEC 282.3
- glucose-6-phosphate dehydrogenase deficiency 282.2
- pyruvate kinase (PK) deficiency 282.3
- type I 282.2
- type II 282.3
- type I 282.2
- type II 282.3
- of or complicating pregnancy 648.2
- resulting from presence of shunt or other internal prosthetic device 283.19
- secondary 283.19
- sickle-cell - see Disease, sickle-cell
- Stransky-Regala type (Hb-E) (see also Disease, hemoglobin) 282.7
- symptomatic 283.19
- toxic (acquired) 283.19
- uremic (adult) (child) 283.11
- warm type (secondary) (symptomatic) 283.0
- pentose phosphate pathway deficiency 282.2
- Deficiency, deficient
- 6-phosphogluconic dehydrogenase (anemia) 282.2
- erythrocytic glutathione (anemia) 282.2
- glucose-6-phosphate dehydrogenase anemia 282.2
- glutathione-reductase (anemia) 282.2
- hexose monophosphate (HMP) shunt 282.2
- Disorder - see also Disease
- pentose phosphate pathway with anemia 282.2
- Favism (anemia) 282.2
- Poisoning (acute) - see also Table of Drugs and Chemicals
- fava bean 282.2
- Toxicity
- fava bean 282.2